Product Program year 2025 Source: CMS Open Payments

Winlevi

Drug Dermatology

NDC 47335-994-36

Open in the dashboard

General payments

$4,381,613

73,903 payments

Research payments

$5,875

16 payments

Through program year 2025, $4,381,613 in general payments and $5,875 in research payments were reported against Winlevi (Dermatology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $1,072,455 15,202
2024 General $748,956 17,320
2024 Research $5,875 16
2023 General $1,064,118 20,629
2022 General $1,059,194 16,829
2021 General $436,891 3,923

Breakdown

Who paid General payments · program years 2021–2025
  1. Sun Pharmaceutical Industries Inc. $4,381,613 73,903 payments
Top recipients General payments · program year 2025
  1. Hilary Baldwin Dermatology · Brooklyn, NY $195,153 18% · 166 payments
  2. Leon Kircik Dermatology · Lousiville, KY $71,282 7% · 52 payments
  3. A Brunner Physician Assistant · Stockbridge, GA $51,608 5% · 111 payments
  4. Julie Harper Dermatology · Birmingham, AL $50,633 5% · 30 payments
  5. Adelaide Hebert Pediatric Dermatology · Bellaire, TX $50,326 5% · 39 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Dermatology $635,736 60% · 2,229 practitioners
  2. Physician Assistant $182,482 17% · 1,892 practitioners
  3. Pediatric Dermatology Dermatology $77,854 7% · 13 practitioners
  4. Physician Assistant, Medical Physician Assistant $48,779 5% · 479 practitioners
  5. MOHS-Micrographic Surgery Dermatology $30,035 3% · 156 practitioners

The top 5 of 66 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New Jersey $212,198 20% · 292 recipients
  2. Texas $121,722 11% · 507 recipients
  3. Florida $100,961 9% · 507 recipients
  4. New York $95,300 9% · 679 recipients
  5. California $86,924 8% · 646 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

Prescribed to Medicare patients

Part D · data year 2024

Part D claims

244

Prescriptions dispensed, refills included

Drug cost

$139,030

Paid at the pharmacy, in all

Prescribers

13

With 11 or more claims of it

Medicare Part D drugs matched to Winlevi, 2024
Part D drug Name match Relative to the largest Prescribers Claims Drug cost
Winlevi Clascoterone Same name 13 244 $139,030

Matched to this product by name; CMS does not link its files to Open Payments, so a similar name can be a different strength, form or brand. Prescriber counts include only prescribers with 11 or more claims of the drug, because CMS publishes nothing below that. Part D covers drugs dispensed to Medicare beneficiaries at a pharmacy; it does not include drugs given in a clinic or hospital, or patients with other insurance.

Largest prescribers

First 5 of 13 by claims · 2024

Two separate records. Claims come from Medicare and related payments from Open Payments. They are shown in one row because they name the same product; they do not show that a payment affected a prescription.

The prescribers with the most Part D claims of this drug in 2024
Prescriber Specialty State Claims Drug cost Related payments
Jeffrey Baird Family Practice AZ 72 $39,387 None on record
Liliya Besedina Dermatology NJ 24 $13,777 $25
Kristina Campton Dermatology NY 22 $12,345 $374
Curtis Chen Physician Assistant NY 17 $9,503 $236
Nicole Minogue Physician Assistant NY 16 $8,761 $21

"No profile" means the prescriber has no Open Payments record here; "None on record" means no payment naming this product in the payment year. Related payments are general payments, and one that names several products is split evenly, so an amount is payments related to the product, not money paid for it. The list is the prescribers with the most claims, up to 100 per drug.

See all 13 in the dashboard with a free account
73,903 general · 16 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record